SELLAS Life Sciences Group, Inc. — Director's Dealing 2016

Jul 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2016-07-01

Reporting Person: SCHWARTZ MARK W. (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-01	Common Stock	J	8503	$0.3995	Acquired	439978	Direct

Footnotes

F1: Pursuant to the Issuer's Employee Stock Purchase Plan